gene chip human mapping array 6.0 Search Results


93
Novus Biologicals med12
TET3 affects DNA methylation and histone modifications of the <t>MED12,</t> TGFBR2, and TSP1 promoters. a UtLM cells were transfected with siCon or siTET3 for 48 h, followed by ChIP-qPCR analysis. Data are presented as mean relative TET3 enrichment over input. n = 3. Red numbers indicate nucleotide positions relative to the transcriptional start sites, with PCR products depicted as red-stripped bars. b Sequences of critical transcription regulatory regions (CTRR) of MED12 , TGFBR2 , and TSP1 . The differentially methylated cytosine residues are marked in red. The red numbers mark the positions of the indicated nucleotides relative to the transcriptional start sites. c UtLM cells were transfected with siCon or siTET3 for 48 h, followed by QMSP analysis. n = 3. d UtLM cells were transfected with siCon or siTET3 for 48 h, followed by ChIP-qPCR analysis. Data are presented as mean relative enrichment over input. n = 3. All data are representative of at least two independent experiments and are presented as mean ± SEM. * p < 0.05, ** p < 0.01
Med12, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+chip+human+mapping+array+6%2E0/MED12+Antibody/pmc06755985-149-29-30
Average 93 stars, based on 1 article reviews
med12 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc saline tween 20 tbst
Primer sequences for RT-qPCR.
Saline Tween 20 Tbst, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+chip+human+mapping+array+6%2E0/Tris+Buffered+Saline+with+Tween+20/pmc07819137-70-20-50
Average 97 stars, based on 1 article reviews
saline tween 20 tbst - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc anti erk1 2
Primary and secondary antibodies
Anti Erk1 2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+chip+human+mapping+array+6%2E0/p44%2F42+MAPK+(Erk1%2F2)+Rabbit+mAb/pmc11462858-17-1-4
Average 99 stars, based on 1 article reviews
anti erk1 2 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

93
Novus Biologicals rabbit a chd8
Dosage-sensitive effect of <t>CHD8</t> deletion on transcription in ESCs. (A) The gnomAD human gene constraint scores (missense and probability of intolerance to heterozygous pLoF variation [pLI] for all genes with CHD8 labeled). (B) Schematic showing the CHD8 CRISPR-mediated deletion approach and Western blot of CHD8 levels in Chd8+/− and Chd8−/− ESC lines. (C) Doubling time of WT, Chd8+/−, and Chd8−/− cells. Asterisks denote P < 0.05 (*). Values are expressed as the mean ± SE, n = 3. (D) Alkaline phosphatase staining of WT, Chd8+/−, and Chd8−/− ESCs in 2i media. Magnification: 200×. (E) Venn diagrams depicting overlap of DEGs in Chd8+/− and Chd8−/− ESCs. Genes with increased expression are on top, and genes with decreased expression are on the bottom (FDR < 0.05). (F) Heatmap showing dosage-sensitive transcriptional response for genes that are differentially expressed in Chd8−/−. (G) GO terms for DEGs (padj < 0.05).
Rabbit A Chd8, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+chip+human+mapping+array+6%2E0/CHD8+Antibody/pmc07486765-402-11-14
Average 93 stars, based on 1 article reviews
rabbit a chd8 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
CH Instruments chi-square test hapmap
Basic demographics according to NRGN rs12541 and <t> rs12807809 </t> genotype.
Chi Square Test Hapmap, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+chip+human+mapping+array+6%2E0/chi+square+test+hapmap/pmc03788740-99-7-8
Average 90 stars, based on 1 article reviews
chi-square test hapmap - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc rabbit anti p44 42 mapk
KEY RESOURCES TABLE
Rabbit Anti P44 42 Mapk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+chip+human+mapping+array+6%2E0/Phospho-p44%2F42+MAPK+(Erk1%2F2)+(Thr202%2FTyr204)+Antibody/pmc07549840-7-0-5
Average 99 stars, based on 1 article reviews
rabbit anti p44 42 mapk - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

90
INFINIUM Inc 450k human methylation bead chip
KEY RESOURCES TABLE
450k Human Methylation Bead Chip, supplied by INFINIUM Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+chip+human+mapping+array+6%2E0/infinium+humanmethylation450+beadchip/pm29470513-27-12-11
Average 90 stars, based on 1 article reviews
450k human methylation bead chip - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CH Instruments consolidated human protein-protein interactome
(A) Protein-protein interaction network analysis was used to clarify the molecular pathways that regulate two functionally distinct fibrosis subtypes: adaptive and pathogenic. Genes related to dermal and vascular fibrosis were collected from the curated literature, focusing on pulmonary arterial hypertension (PAH) as a human disease correlate to these findings in silico. Genes specifically associated with lung fibrosis (n = 362) were excluded from the analysis to limit the probability of analyzing pathways responsible for lung parenchymal fibrosis rather than pulmonary vascular fibrosis. (B) The gene products (proteins) associated with adaptive fibrosis (blue), pathogenic fibrosis (red), or both adaptive and pathogenic fibrosis (blue with red border) were mapped to the consolidated human protein-protein <t>interactome</t> (12), resulting in the fibrosome. (C) An aldosterone (ALDO)-fibrosome protein-protein interactome subnetwork resulting from associations involving fibrosis genes connected to ALDO-regulated genes. Arrow points to the SMAD3 target and Cas protein NEDD9. (D) Betweenness centrality (BC), a measure of importance in information transfer across the network of a node (protein) based on the shortest paths, was used to identify NEDD9 as a critical node in the phenotype transition from adaptive to pathogenic fibrosis. BC of an ALDO-regulated gene (ai) in connecting adaptive and pathogenic fibrosis (F1 and F2, respectively) is the sum of the fraction of all fibrosis gene pairs’ shortest paths in the interactome that pass through this ALDO-regulated gene (t) in the interactome, and σ(s,t|ai) is the number of those shortest paths in the interactome that pass through ALDO-regulated gene ai. The BC score for NEDD9 was ranked 6th of 86 proteins.
Consolidated Human Protein Protein Interactome, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+chip+human+mapping+array+6%2E0/consolidated+human+protein+protein+interactome/pmc06223025-90-14-17
Average 90 stars, based on 1 article reviews
consolidated human protein-protein interactome - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc p38
MEF2C binds to the upstream region of FOS gene and regulates NFATC1 expression. a A schematic view of FOS upstream regions with putative MEF2C binding sites predicted based on the analysis of MEF2C ChIP-sequencing data. b ChIP-qPCR analysis of the three putative MEF2C binding sites in the FOS upstream region. MEF2C binding was assessed in human OCPs transduced with adenoviral particles encoding GFP or MEF2C-FLAG and immunoprecipitated with FLAG antibodies. Dotted line represents enrichment level in the negative control HBB region in GFP transduced samples. ( n = 4) Mouse osteoclast precursor cells from MEF2C ΔMX KO or littermate control WT mice were transduced with retroviral particles encoding GFP or FOS and cultured with M-CSF and RANKL. c Representative image of TRAP staining of mouse osteoclasts. Scale bar, 100 μm. d Cumulative data showing numbers of osteoclasts from four independent experiments. Human osteoclast precursor cells were nucleofected with control or MEF2C #2 siRNAs. e RT-qPCR analysis of human NFATC1 mRNA after 48 h of culture with or without RANKL normalized relative to TBP mRNA (control samples with RANKL set at 1.0). n = 5. f Representative immunoblot of human NFATc1. <t>p38</t> was used as a loading control. Right panel, densitometric quantitation of band intensity from three donors. Mouse osteoclast precursor cells from MEF2C ΔMX mice or littermate control WT mice were cultured with M-CSF and RANKL. g RT-qPCR analysis of mouse Nfatc1 mRNA after 24 h of culture with or without RANKL (50 ng·mL −1 ) normalized relative to Hprt mRNA (control samples without RANKL set at 1.0). WT; n = 11, KO; n = 12. h Representative images of immunoblotting analysis of mouse NFATc1 expression. Right panel, densitometric quantitation of band intensity from 4 samples of each genotype. Data are shown as mean ± SD. Statistics used: e repeated measurement two-way ANOVA, f paired t -test, g two-way ANOVA, h Welch’s t -test. * P < 0.05, ** P < 0.01, *** P < 0.001
P38, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+chip+human+mapping+array+6%2E0/p38+MAPK+Antibody/pmc07797478-200-35-37
Average 99 stars, based on 1 article reviews
p38 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

90
Novus Biologicals antibody against jmjd2b
<t>JMJD2B</t> expression increases in hepatic steatotic cell and animal models. ( A ) HepG2 cells were incubated with a mixture of palmitic acid (PA) and oleic acid (OA) (1:2 ratio) at 800 μM concentrations for 24 h, and intracellular triglyceride (TG) levels were analyzed by a TG assay kit. JMJD2B mRNA and protein levels were examined by qPCR and western blotting, respectively. Data represent means ± SEM of three independent experiments performed in triplicate. *p < 0.05 vs. no treatment. The full-length western blots corresponding to truncated blots are presented in Supplementary Figure . ( B ) HepG2 cells were treated with T0901317 (10 μM) for 24 h, and intracellular triglyceride (TG) levels were measured by a TG assay kit. JMJD2B mRNA and protein levels were examined by qPCR and western blotting, respectively. Data represent means ± SEM of three independent experiments performed in triplicate. *p < 0.05 vs. no treatment. The full-length western blots are presented in Supplementary Figure . ( C ) Total RNAs were isolated from the livers of HFD-induced obese mice. The JMJD2B mRNA levels were assessed by qPCR. Data represent means ± SEM of 5 mice. * p < 0.05 vs. ND mice. ND: normal diet. HFD: high fat diet.
Antibody Against Jmjd2b, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+chip+human+mapping+array+6%2E0/JMJD2B+Antibody/pmc06137221-210-1-8
Average 90 stars, based on 1 article reviews
antibody against jmjd2b - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc antibodies against yy1
<t>JMJD2B</t> expression increases in hepatic steatotic cell and animal models. ( A ) HepG2 cells were incubated with a mixture of palmitic acid (PA) and oleic acid (OA) (1:2 ratio) at 800 μM concentrations for 24 h, and intracellular triglyceride (TG) levels were analyzed by a TG assay kit. JMJD2B mRNA and protein levels were examined by qPCR and western blotting, respectively. Data represent means ± SEM of three independent experiments performed in triplicate. *p < 0.05 vs. no treatment. The full-length western blots corresponding to truncated blots are presented in Supplementary Figure . ( B ) HepG2 cells were treated with T0901317 (10 μM) for 24 h, and intracellular triglyceride (TG) levels were measured by a TG assay kit. JMJD2B mRNA and protein levels were examined by qPCR and western blotting, respectively. Data represent means ± SEM of three independent experiments performed in triplicate. *p < 0.05 vs. no treatment. The full-length western blots are presented in Supplementary Figure . ( C ) Total RNAs were isolated from the livers of HFD-induced obese mice. The JMJD2B mRNA levels were assessed by qPCR. Data represent means ± SEM of 5 mice. * p < 0.05 vs. ND mice. ND: normal diet. HFD: high fat diet.
Antibodies Against Yy1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+chip+human+mapping+array+6%2E0/YY1+Rabbit+mAb/ppr0570480-152-9-12
Average 96 stars, based on 1 article reviews
antibodies against yy1 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

92
Novus Biologicals rnf20 chip grade
<t>JMJD2B</t> expression increases in hepatic steatotic cell and animal models. ( A ) HepG2 cells were incubated with a mixture of palmitic acid (PA) and oleic acid (OA) (1:2 ratio) at 800 μM concentrations for 24 h, and intracellular triglyceride (TG) levels were analyzed by a TG assay kit. JMJD2B mRNA and protein levels were examined by qPCR and western blotting, respectively. Data represent means ± SEM of three independent experiments performed in triplicate. *p < 0.05 vs. no treatment. The full-length western blots corresponding to truncated blots are presented in Supplementary Figure . ( B ) HepG2 cells were treated with T0901317 (10 μM) for 24 h, and intracellular triglyceride (TG) levels were measured by a TG assay kit. JMJD2B mRNA and protein levels were examined by qPCR and western blotting, respectively. Data represent means ± SEM of three independent experiments performed in triplicate. *p < 0.05 vs. no treatment. The full-length western blots are presented in Supplementary Figure . ( C ) Total RNAs were isolated from the livers of HFD-induced obese mice. The JMJD2B mRNA levels were assessed by qPCR. Data represent means ± SEM of 5 mice. * p < 0.05 vs. ND mice. ND: normal diet. HFD: high fat diet.
Rnf20 Chip Grade, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+chip+human+mapping+array+6%2E0/RNF20+Antibody/pmc02940767-170-94-95
Average 92 stars, based on 1 article reviews
rnf20 chip grade - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

Image Search Results


TET3 affects DNA methylation and histone modifications of the MED12, TGFBR2, and TSP1 promoters. a UtLM cells were transfected with siCon or siTET3 for 48 h, followed by ChIP-qPCR analysis. Data are presented as mean relative TET3 enrichment over input. n = 3. Red numbers indicate nucleotide positions relative to the transcriptional start sites, with PCR products depicted as red-stripped bars. b Sequences of critical transcription regulatory regions (CTRR) of MED12 , TGFBR2 , and TSP1 . The differentially methylated cytosine residues are marked in red. The red numbers mark the positions of the indicated nucleotides relative to the transcriptional start sites. c UtLM cells were transfected with siCon or siTET3 for 48 h, followed by QMSP analysis. n = 3. d UtLM cells were transfected with siCon or siTET3 for 48 h, followed by ChIP-qPCR analysis. Data are presented as mean relative enrichment over input. n = 3. All data are representative of at least two independent experiments and are presented as mean ± SEM. * p < 0.05, ** p < 0.01

Journal: Oncogene

Article Title: H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas

doi: 10.1038/s41388-019-0808-4

Figure Lengend Snippet: TET3 affects DNA methylation and histone modifications of the MED12, TGFBR2, and TSP1 promoters. a UtLM cells were transfected with siCon or siTET3 for 48 h, followed by ChIP-qPCR analysis. Data are presented as mean relative TET3 enrichment over input. n = 3. Red numbers indicate nucleotide positions relative to the transcriptional start sites, with PCR products depicted as red-stripped bars. b Sequences of critical transcription regulatory regions (CTRR) of MED12 , TGFBR2 , and TSP1 . The differentially methylated cytosine residues are marked in red. The red numbers mark the positions of the indicated nucleotides relative to the transcriptional start sites. c UtLM cells were transfected with siCon or siTET3 for 48 h, followed by QMSP analysis. n = 3. d UtLM cells were transfected with siCon or siTET3 for 48 h, followed by ChIP-qPCR analysis. Data are presented as mean relative enrichment over input. n = 3. All data are representative of at least two independent experiments and are presented as mean ± SEM. * p < 0.05, ** p < 0.01

Article Snippet: Antibodies for TET3 (GeneTex, GTX121453; used at a dilution of 1/500), TGFBR2 (Abcam, ab184948; used at a dilution of 1/1000), TSP1 (Abcam, ab85762; used at a dilution of 1/500), MED12 (Novus Biological, NB100–2357; used at a dilution of 1/500), HMGA2 (Proteintech, 20795–1-AP; used at a dilution of 1/500), GRAF1 (Cell Signaling, 8802; used at a dilution of 1/500), SPARC (Cell Signaling, 8725; used at a dilution of 1/500), COL3A1 (LS-Bio, LS-C159386; used at a dilution of 1/1000), COL4A1 (LS-Bio, LS-C100552; used at a dilution of 1/500), COL5A2 (Origene, TA809611; used at a dilution of 1/500), and GAPDH (Abcam, ab128915; used at a dilution of 1/10000) were purchased.

Techniques: DNA Methylation Assay, Transfection, ChIP-qPCR, Methylation

H19 and TET3 co-express with fibroid-promoting genes in vivo. a , c RT-qPCR analyses were performed on RNAs extracted from human fibroids and matched myometrium tissues. Spearman’s correlation showed positive correlations between expression of H19 and TET3 ( a , left panel), as well as TET3 and its target genes MED12 , TGFBR2 , and TSP1 ( c ) in a statistically significant manner. No correlation between expression of H19 and HMGA2 at the RNA level was detected ( a , right panel). Spearman’s correlation coefficient, p -values, and sample numbers are presented. b Results of western blotting analysis of HMGA2 in human fibroids and matched myometrium. n = 3. Data are representative of two independent experiments and are presented as mean ± SEM

Journal: Oncogene

Article Title: H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas

doi: 10.1038/s41388-019-0808-4

Figure Lengend Snippet: H19 and TET3 co-express with fibroid-promoting genes in vivo. a , c RT-qPCR analyses were performed on RNAs extracted from human fibroids and matched myometrium tissues. Spearman’s correlation showed positive correlations between expression of H19 and TET3 ( a , left panel), as well as TET3 and its target genes MED12 , TGFBR2 , and TSP1 ( c ) in a statistically significant manner. No correlation between expression of H19 and HMGA2 at the RNA level was detected ( a , right panel). Spearman’s correlation coefficient, p -values, and sample numbers are presented. b Results of western blotting analysis of HMGA2 in human fibroids and matched myometrium. n = 3. Data are representative of two independent experiments and are presented as mean ± SEM

Article Snippet: Antibodies for TET3 (GeneTex, GTX121453; used at a dilution of 1/500), TGFBR2 (Abcam, ab184948; used at a dilution of 1/1000), TSP1 (Abcam, ab85762; used at a dilution of 1/500), MED12 (Novus Biological, NB100–2357; used at a dilution of 1/500), HMGA2 (Proteintech, 20795–1-AP; used at a dilution of 1/500), GRAF1 (Cell Signaling, 8802; used at a dilution of 1/500), SPARC (Cell Signaling, 8725; used at a dilution of 1/500), COL3A1 (LS-Bio, LS-C159386; used at a dilution of 1/1000), COL4A1 (LS-Bio, LS-C100552; used at a dilution of 1/500), COL5A2 (Origene, TA809611; used at a dilution of 1/500), and GAPDH (Abcam, ab128915; used at a dilution of 1/10000) were purchased.

Techniques: In Vivo, Quantitative RT-PCR, Expressing, Western Blot

Primer sequences for RT-qPCR.

Journal: Frontiers in Oncology

Article Title: E2F7 Transcriptionally Inhibits MicroRNA-199b Expression to Promote USP47, Thereby Enhancing Colon Cancer Tumor Stem Cell Activity and Promoting the Occurrence of Colon Cancer

doi: 10.3389/fonc.2020.565449

Figure Lengend Snippet: Primer sequences for RT-qPCR.

Article Snippet: The membrane was blocked with 5% skimmed milk powder for 1 h, added with primary rabbit antibodies diluted with Tris-buffered saline Tween-20 (TBST) (E2F7, ab56022, 1:1,000; USP47, ab72143, 1:1,000; GAPDH, EPR16891, 1:3,000; K48 ubiquitin, EP8589, 1:1,000; FLAG, ab205606; HA, ab187915, Abcam Inc., Cambridge, UK; MAPK, and p44/42 MAPK [Erk1/2; #9102, Cell Signaling Technologies, Beverly, MA, USA]), and incubated overnight at 4°C.

Techniques:

E2F7 is overexpressed in colon cancer tissues and negatively correlates with the survival rate of patients. (A) E2F7 expression in cancer tissues and adjacent normal tissues collected from 30 patients with colon cancer determined by RT-qPCR. The Y axis indicates the relative expression of E2F7 mRNA. (B) Immunohistochemical staining analysis of E2F7 protein in three pairs of colon cancer tissues and adjacent normal tissues (×200). (C) The expression of E2F7 in colon cancer tissues of the GEPIA2 database, where red indicates tumor samples and gray indicates normal tissues. The Y axis indicates the relative expression of E2F7 mRNA. (D) Correlation of survival rate of patients with E2F7 expression analyzed by a survival curve. X axis indicates time, and Y axis indicates survival rate. * p < 0.05. Data between colon cancer tissues and adjacent normal tissues were compared using paired t -test. The experiment was repeated three times independently.

Journal: Frontiers in Oncology

Article Title: E2F7 Transcriptionally Inhibits MicroRNA-199b Expression to Promote USP47, Thereby Enhancing Colon Cancer Tumor Stem Cell Activity and Promoting the Occurrence of Colon Cancer

doi: 10.3389/fonc.2020.565449

Figure Lengend Snippet: E2F7 is overexpressed in colon cancer tissues and negatively correlates with the survival rate of patients. (A) E2F7 expression in cancer tissues and adjacent normal tissues collected from 30 patients with colon cancer determined by RT-qPCR. The Y axis indicates the relative expression of E2F7 mRNA. (B) Immunohistochemical staining analysis of E2F7 protein in three pairs of colon cancer tissues and adjacent normal tissues (×200). (C) The expression of E2F7 in colon cancer tissues of the GEPIA2 database, where red indicates tumor samples and gray indicates normal tissues. The Y axis indicates the relative expression of E2F7 mRNA. (D) Correlation of survival rate of patients with E2F7 expression analyzed by a survival curve. X axis indicates time, and Y axis indicates survival rate. * p < 0.05. Data between colon cancer tissues and adjacent normal tissues were compared using paired t -test. The experiment was repeated three times independently.

Article Snippet: The membrane was blocked with 5% skimmed milk powder for 1 h, added with primary rabbit antibodies diluted with Tris-buffered saline Tween-20 (TBST) (E2F7, ab56022, 1:1,000; USP47, ab72143, 1:1,000; GAPDH, EPR16891, 1:3,000; K48 ubiquitin, EP8589, 1:1,000; FLAG, ab205606; HA, ab187915, Abcam Inc., Cambridge, UK; MAPK, and p44/42 MAPK [Erk1/2; #9102, Cell Signaling Technologies, Beverly, MA, USA]), and incubated overnight at 4°C.

Techniques: Expressing, Quantitative RT-PCR, Immunohistochemical staining, Staining

E2F7 silencing suppresses the stemness of colon cancer stem cells. (A) Flow cytometry and quantitative analysis of the proportion of ALDH1 + cells in SW403 cells transfected with shE2F7. (B) Flow cytometry and quantitative analysis of the changes in the proportion of ALDH1 + cells in SW620 cells transfected with shE2F7. (C) Flow cytometry and quantitative analysis of the proportion of CD133+ cells in SW403 cells transfected with shE2F7. (D) Flow cytometry and quantitative analysis of the proportion of CD133+ cells in SW620 cells transfected with shE2F7. (E) SW403 cell stemness determined by sphere formation test upon transfection with shE2F7. (F) SW620 cell stemness determined by sphere formation test upon transfection with shE2F7. Data between two groups were compared using unpaired t -test. * p < 0.05. The experiment was repeated three times independently.

Journal: Frontiers in Oncology

Article Title: E2F7 Transcriptionally Inhibits MicroRNA-199b Expression to Promote USP47, Thereby Enhancing Colon Cancer Tumor Stem Cell Activity and Promoting the Occurrence of Colon Cancer

doi: 10.3389/fonc.2020.565449

Figure Lengend Snippet: E2F7 silencing suppresses the stemness of colon cancer stem cells. (A) Flow cytometry and quantitative analysis of the proportion of ALDH1 + cells in SW403 cells transfected with shE2F7. (B) Flow cytometry and quantitative analysis of the changes in the proportion of ALDH1 + cells in SW620 cells transfected with shE2F7. (C) Flow cytometry and quantitative analysis of the proportion of CD133+ cells in SW403 cells transfected with shE2F7. (D) Flow cytometry and quantitative analysis of the proportion of CD133+ cells in SW620 cells transfected with shE2F7. (E) SW403 cell stemness determined by sphere formation test upon transfection with shE2F7. (F) SW620 cell stemness determined by sphere formation test upon transfection with shE2F7. Data between two groups were compared using unpaired t -test. * p < 0.05. The experiment was repeated three times independently.

Article Snippet: The membrane was blocked with 5% skimmed milk powder for 1 h, added with primary rabbit antibodies diluted with Tris-buffered saline Tween-20 (TBST) (E2F7, ab56022, 1:1,000; USP47, ab72143, 1:1,000; GAPDH, EPR16891, 1:3,000; K48 ubiquitin, EP8589, 1:1,000; FLAG, ab205606; HA, ab187915, Abcam Inc., Cambridge, UK; MAPK, and p44/42 MAPK [Erk1/2; #9102, Cell Signaling Technologies, Beverly, MA, USA]), and incubated overnight at 4°C.

Techniques: Flow Cytometry, Transfection

E2F7 silencing represses antagonistic effects of ALDH1 + cells on 5-FU treatment and oxidative stress. (A) In SW403, flow cytometry and quantitative analysis of the effect of E2F7 silencing on antagonism of ALDH1 + cell to effects of 5-FU treatment. (B) In SW403 cells, flow cytometry and quantitative analysis of the effect of E2F7 silencing on antagonism of ALDH1 + cells to H 2 O 2 treatment. (C) In SW620 cells, flow cytometry and quantitative analysis of the effect of E2F7 on ALDH1 + cell antagonist 5-FU. (D) In SW620 cells, flow cytometry and quantitative analysis of the effect of E2F7 on ALDH1 + cells antagonizing H 2 O 2 treatment. Data between two groups were compared using unpaired t -test. * p < 0.05. The experiment was repeated three times independently.

Journal: Frontiers in Oncology

Article Title: E2F7 Transcriptionally Inhibits MicroRNA-199b Expression to Promote USP47, Thereby Enhancing Colon Cancer Tumor Stem Cell Activity and Promoting the Occurrence of Colon Cancer

doi: 10.3389/fonc.2020.565449

Figure Lengend Snippet: E2F7 silencing represses antagonistic effects of ALDH1 + cells on 5-FU treatment and oxidative stress. (A) In SW403, flow cytometry and quantitative analysis of the effect of E2F7 silencing on antagonism of ALDH1 + cell to effects of 5-FU treatment. (B) In SW403 cells, flow cytometry and quantitative analysis of the effect of E2F7 silencing on antagonism of ALDH1 + cells to H 2 O 2 treatment. (C) In SW620 cells, flow cytometry and quantitative analysis of the effect of E2F7 on ALDH1 + cell antagonist 5-FU. (D) In SW620 cells, flow cytometry and quantitative analysis of the effect of E2F7 on ALDH1 + cells antagonizing H 2 O 2 treatment. Data between two groups were compared using unpaired t -test. * p < 0.05. The experiment was repeated three times independently.

Article Snippet: The membrane was blocked with 5% skimmed milk powder for 1 h, added with primary rabbit antibodies diluted with Tris-buffered saline Tween-20 (TBST) (E2F7, ab56022, 1:1,000; USP47, ab72143, 1:1,000; GAPDH, EPR16891, 1:3,000; K48 ubiquitin, EP8589, 1:1,000; FLAG, ab205606; HA, ab187915, Abcam Inc., Cambridge, UK; MAPK, and p44/42 MAPK [Erk1/2; #9102, Cell Signaling Technologies, Beverly, MA, USA]), and incubated overnight at 4°C.

Techniques: Flow Cytometry

E2F7 reduces miR-199b expression by binding to the miR-199b promoter. (A) Analysis of Motif of E2F7 through the cistromeDB database. (B) Visualization of ChIP-seq results of miR-199b targeting E2F7 in the hTFtarget database. (C) Expression of miR-199b determined by RT-qPCR in SW403 cells transfected with shE2F7 or miR-199b inhibitor. (D) miR-199b expression in colon cancer tissues and adjacent normal tissues determined by RT-qPCR (n = 30). (E) Binding of E2F7 to the miR-199 promoter region confirmed by luciferase reporter gene assay. (F) Binding of E2F7 to the miR-199 promoter region analyzed by ChIP assay. Data between colon cancer tissues and adjacent normal tissues were compared using paired t- test, while data between other two groups were compared using unpaired t -test. Comparisons among multiple groups were conducted by one-way ANOVA followed by Tukey’s post hoc test. * p < 0.05. The experiment was repeated three times independently.

Journal: Frontiers in Oncology

Article Title: E2F7 Transcriptionally Inhibits MicroRNA-199b Expression to Promote USP47, Thereby Enhancing Colon Cancer Tumor Stem Cell Activity and Promoting the Occurrence of Colon Cancer

doi: 10.3389/fonc.2020.565449

Figure Lengend Snippet: E2F7 reduces miR-199b expression by binding to the miR-199b promoter. (A) Analysis of Motif of E2F7 through the cistromeDB database. (B) Visualization of ChIP-seq results of miR-199b targeting E2F7 in the hTFtarget database. (C) Expression of miR-199b determined by RT-qPCR in SW403 cells transfected with shE2F7 or miR-199b inhibitor. (D) miR-199b expression in colon cancer tissues and adjacent normal tissues determined by RT-qPCR (n = 30). (E) Binding of E2F7 to the miR-199 promoter region confirmed by luciferase reporter gene assay. (F) Binding of E2F7 to the miR-199 promoter region analyzed by ChIP assay. Data between colon cancer tissues and adjacent normal tissues were compared using paired t- test, while data between other two groups were compared using unpaired t -test. Comparisons among multiple groups were conducted by one-way ANOVA followed by Tukey’s post hoc test. * p < 0.05. The experiment was repeated three times independently.

Article Snippet: The membrane was blocked with 5% skimmed milk powder for 1 h, added with primary rabbit antibodies diluted with Tris-buffered saline Tween-20 (TBST) (E2F7, ab56022, 1:1,000; USP47, ab72143, 1:1,000; GAPDH, EPR16891, 1:3,000; K48 ubiquitin, EP8589, 1:1,000; FLAG, ab205606; HA, ab187915, Abcam Inc., Cambridge, UK; MAPK, and p44/42 MAPK [Erk1/2; #9102, Cell Signaling Technologies, Beverly, MA, USA]), and incubated overnight at 4°C.

Techniques: Expressing, Binding Assay, ChIP-sequencing, Quantitative RT-PCR, Transfection, Luciferase, Reporter Gene Assay

USP47 is a target gene of miR-199b in SW403 cells. (A) Prediction of lowly expressed target gene set of miR-199b by starBase, miDIP, and DianaTools. (B) The expression of USP47 in colon cancer tissues in the GEPIA2 database, where red indicates tumor samples and gray indicates normal tissues. (C) Putative miR-199b binding sites in the 3′UTR of UPS47 mRNA. (D) Binding of miR-199b to USP47 confirmed by dual luciferase reporter gene assay. (E) RNA pull-down analysis of the interaction between miR-199b and GST-USP47 in vitro . (F) USP47 expression determined by RT-qPCR and Western blot analysis in cells transfected with miR-199b or miR-199b inhibitor. (G) USP47 expression determined by RT-qPCR and Western blot analysis in cells transfected with shE2F7. Comparisons among multiple groups were conducted by one-way ANOVA followed by Tukey’s post hoc test. Data between two groups were compared using unpaired t- test. * p < 0.05. The experiment was repeated three times independently.

Journal: Frontiers in Oncology

Article Title: E2F7 Transcriptionally Inhibits MicroRNA-199b Expression to Promote USP47, Thereby Enhancing Colon Cancer Tumor Stem Cell Activity and Promoting the Occurrence of Colon Cancer

doi: 10.3389/fonc.2020.565449

Figure Lengend Snippet: USP47 is a target gene of miR-199b in SW403 cells. (A) Prediction of lowly expressed target gene set of miR-199b by starBase, miDIP, and DianaTools. (B) The expression of USP47 in colon cancer tissues in the GEPIA2 database, where red indicates tumor samples and gray indicates normal tissues. (C) Putative miR-199b binding sites in the 3′UTR of UPS47 mRNA. (D) Binding of miR-199b to USP47 confirmed by dual luciferase reporter gene assay. (E) RNA pull-down analysis of the interaction between miR-199b and GST-USP47 in vitro . (F) USP47 expression determined by RT-qPCR and Western blot analysis in cells transfected with miR-199b or miR-199b inhibitor. (G) USP47 expression determined by RT-qPCR and Western blot analysis in cells transfected with shE2F7. Comparisons among multiple groups were conducted by one-way ANOVA followed by Tukey’s post hoc test. Data between two groups were compared using unpaired t- test. * p < 0.05. The experiment was repeated three times independently.

Article Snippet: The membrane was blocked with 5% skimmed milk powder for 1 h, added with primary rabbit antibodies diluted with Tris-buffered saline Tween-20 (TBST) (E2F7, ab56022, 1:1,000; USP47, ab72143, 1:1,000; GAPDH, EPR16891, 1:3,000; K48 ubiquitin, EP8589, 1:1,000; FLAG, ab205606; HA, ab187915, Abcam Inc., Cambridge, UK; MAPK, and p44/42 MAPK [Erk1/2; #9102, Cell Signaling Technologies, Beverly, MA, USA]), and incubated overnight at 4°C.

Techniques: Expressing, Binding Assay, Luciferase, Reporter Gene Assay, In Vitro, Quantitative RT-PCR, Western Blot, Transfection

USP47 upregulation by E2F7 deubiquitin-modifies MAPK K48 ubiquitin chain to stabilize MAPK. (A) Protein expression of MAPK in three pairs of colon cancer tissues (T) and adjacent normal tissues (N) determined by Western blot analysis. (B) Detection of the interaction between USP47 and MAPK in 293T cells and SW403 cells. (C) GST pull-down analysis of the interaction between USP47 and MAPK in vitro . (D) In 293T cells, detection of the type of MAPK deubiquitin by USP47. (E) In SW403 cells, detection of MAPK deubiquitination. (F) MAPK expression determined by Western blot analysis in SW403 and SW620 cells transfected with shE2F7. The experiment was repeated three times independently.

Journal: Frontiers in Oncology

Article Title: E2F7 Transcriptionally Inhibits MicroRNA-199b Expression to Promote USP47, Thereby Enhancing Colon Cancer Tumor Stem Cell Activity and Promoting the Occurrence of Colon Cancer

doi: 10.3389/fonc.2020.565449

Figure Lengend Snippet: USP47 upregulation by E2F7 deubiquitin-modifies MAPK K48 ubiquitin chain to stabilize MAPK. (A) Protein expression of MAPK in three pairs of colon cancer tissues (T) and adjacent normal tissues (N) determined by Western blot analysis. (B) Detection of the interaction between USP47 and MAPK in 293T cells and SW403 cells. (C) GST pull-down analysis of the interaction between USP47 and MAPK in vitro . (D) In 293T cells, detection of the type of MAPK deubiquitin by USP47. (E) In SW403 cells, detection of MAPK deubiquitination. (F) MAPK expression determined by Western blot analysis in SW403 and SW620 cells transfected with shE2F7. The experiment was repeated three times independently.

Article Snippet: The membrane was blocked with 5% skimmed milk powder for 1 h, added with primary rabbit antibodies diluted with Tris-buffered saline Tween-20 (TBST) (E2F7, ab56022, 1:1,000; USP47, ab72143, 1:1,000; GAPDH, EPR16891, 1:3,000; K48 ubiquitin, EP8589, 1:1,000; FLAG, ab205606; HA, ab187915, Abcam Inc., Cambridge, UK; MAPK, and p44/42 MAPK [Erk1/2; #9102, Cell Signaling Technologies, Beverly, MA, USA]), and incubated overnight at 4°C.

Techniques: Expressing, Western Blot, In Vitro, Transfection

E2F7 promotes in vitro proliferation, invasion, and migration, and in vivo tumorigenesis of colon cancer cells by upregulating MAPK expression. (A) Detection of SW403 cell proliferation by EdU assay (×200). (B) Detection of the migration of SW403 cells by scratch test. (C) Detection of SW403 cell invasion by Transwell assay. (D) Tumor size and weight of mice (n = 10). Comparisons among multiple groups were conducted by one-way ANOVA followed by Tukey’s post hoc test. * p < 0.05. The experiment was repeated three times independently.

Journal: Frontiers in Oncology

Article Title: E2F7 Transcriptionally Inhibits MicroRNA-199b Expression to Promote USP47, Thereby Enhancing Colon Cancer Tumor Stem Cell Activity and Promoting the Occurrence of Colon Cancer

doi: 10.3389/fonc.2020.565449

Figure Lengend Snippet: E2F7 promotes in vitro proliferation, invasion, and migration, and in vivo tumorigenesis of colon cancer cells by upregulating MAPK expression. (A) Detection of SW403 cell proliferation by EdU assay (×200). (B) Detection of the migration of SW403 cells by scratch test. (C) Detection of SW403 cell invasion by Transwell assay. (D) Tumor size and weight of mice (n = 10). Comparisons among multiple groups were conducted by one-way ANOVA followed by Tukey’s post hoc test. * p < 0.05. The experiment was repeated three times independently.

Article Snippet: The membrane was blocked with 5% skimmed milk powder for 1 h, added with primary rabbit antibodies diluted with Tris-buffered saline Tween-20 (TBST) (E2F7, ab56022, 1:1,000; USP47, ab72143, 1:1,000; GAPDH, EPR16891, 1:3,000; K48 ubiquitin, EP8589, 1:1,000; FLAG, ab205606; HA, ab187915, Abcam Inc., Cambridge, UK; MAPK, and p44/42 MAPK [Erk1/2; #9102, Cell Signaling Technologies, Beverly, MA, USA]), and incubated overnight at 4°C.

Techniques: In Vitro, Migration, In Vivo, Expressing, EdU Assay, Transwell Assay

The mechanism of E2F7 in colon cancer. E2F7 inhibited miR-199b expression and consequently upregulated the miR-199b target USP47, thus stabilizing MAPK protein and inducing the increase of the cancer stem cell activity, which would then be responsible for the aggravation of colon cancer.

Journal: Frontiers in Oncology

Article Title: E2F7 Transcriptionally Inhibits MicroRNA-199b Expression to Promote USP47, Thereby Enhancing Colon Cancer Tumor Stem Cell Activity and Promoting the Occurrence of Colon Cancer

doi: 10.3389/fonc.2020.565449

Figure Lengend Snippet: The mechanism of E2F7 in colon cancer. E2F7 inhibited miR-199b expression and consequently upregulated the miR-199b target USP47, thus stabilizing MAPK protein and inducing the increase of the cancer stem cell activity, which would then be responsible for the aggravation of colon cancer.

Article Snippet: The membrane was blocked with 5% skimmed milk powder for 1 h, added with primary rabbit antibodies diluted with Tris-buffered saline Tween-20 (TBST) (E2F7, ab56022, 1:1,000; USP47, ab72143, 1:1,000; GAPDH, EPR16891, 1:3,000; K48 ubiquitin, EP8589, 1:1,000; FLAG, ab205606; HA, ab187915, Abcam Inc., Cambridge, UK; MAPK, and p44/42 MAPK [Erk1/2; #9102, Cell Signaling Technologies, Beverly, MA, USA]), and incubated overnight at 4°C.

Techniques: Expressing, Activity Assay

Primary and secondary antibodies

Journal: Stem Cell Research & Therapy

Article Title: SMYD1 modulates the proliferation of multipotent cardiac progenitor cells derived from human pluripotent stem cells during myocardial differentiation through GSK3β/β-catenin&ERK signaling

doi: 10.1186/s13287-024-03899-7

Figure Lengend Snippet: Primary and secondary antibodies

Article Snippet: , Anti- ERK1/2 , Cell Signaling Technology #4695 , Rabbit , Western blot , 1:1000.

Techniques: Immunofluorescence, Western Blot, Flow Cytometry, ChIP-chip

Dosage-sensitive effect of CHD8 deletion on transcription in ESCs. (A) The gnomAD human gene constraint scores (missense and probability of intolerance to heterozygous pLoF variation [pLI] for all genes with CHD8 labeled). (B) Schematic showing the CHD8 CRISPR-mediated deletion approach and Western blot of CHD8 levels in Chd8+/− and Chd8−/− ESC lines. (C) Doubling time of WT, Chd8+/−, and Chd8−/− cells. Asterisks denote P < 0.05 (*). Values are expressed as the mean ± SE, n = 3. (D) Alkaline phosphatase staining of WT, Chd8+/−, and Chd8−/− ESCs in 2i media. Magnification: 200×. (E) Venn diagrams depicting overlap of DEGs in Chd8+/− and Chd8−/− ESCs. Genes with increased expression are on top, and genes with decreased expression are on the bottom (FDR < 0.05). (F) Heatmap showing dosage-sensitive transcriptional response for genes that are differentially expressed in Chd8−/−. (G) GO terms for DEGs (padj < 0.05).

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: CHD8 dosage regulates transcription in pluripotency and early murine neural differentiation

doi: 10.1073/pnas.1921963117

Figure Lengend Snippet: Dosage-sensitive effect of CHD8 deletion on transcription in ESCs. (A) The gnomAD human gene constraint scores (missense and probability of intolerance to heterozygous pLoF variation [pLI] for all genes with CHD8 labeled). (B) Schematic showing the CHD8 CRISPR-mediated deletion approach and Western blot of CHD8 levels in Chd8+/− and Chd8−/− ESC lines. (C) Doubling time of WT, Chd8+/−, and Chd8−/− cells. Asterisks denote P < 0.05 (*). Values are expressed as the mean ± SE, n = 3. (D) Alkaline phosphatase staining of WT, Chd8+/−, and Chd8−/− ESCs in 2i media. Magnification: 200×. (E) Venn diagrams depicting overlap of DEGs in Chd8+/− and Chd8−/− ESCs. Genes with increased expression are on top, and genes with decreased expression are on the bottom (FDR < 0.05). (F) Heatmap showing dosage-sensitive transcriptional response for genes that are differentially expressed in Chd8−/−. (G) GO terms for DEGs (padj < 0.05).

Article Snippet: Antibodies used in this study are mouse a-FLAG M2 (1:1,000, Sigma-Aldrich), rabbit a-CHD8 (1:2,500, Novus Biologicals #NB100-60417; 1:2,000, Novus Biologicals #NB100-60418), mouse a-TBP (1:2,000, Abcam #ab818), rabbit a-DCX (1:200, CST #4604S), mouse a-Nestin (1:200, #MAB353), mouse a-Tuj1 (1:200, BioLegend #801201), rabbit a-Pax6 (1:200, BioLegend #901301), rabbit a-NeuroD1 (1:200, Proteintech #12081-1-AP), and mouse a-Map2a (1:200, M9942).

Techniques: Labeling, CRISPR, Western Blot, Staining, Expressing

CHD8 deletion results in up-regulation of neuronal genes and Sox TFs during differentiation into NPCs. (A) Schematic showing the differentiation of WT, Chd8+/−, and Chd8−/− ESCs into NPCs. (B) Venn diagrams depicting overlap of DEGs in Chd8+/− and Chd8−/− NPCs. Genes with increased gene expression are on top, and genes with decreased expression are on bottom (FDR < 0.05). (C) Heatmap showing dosage sensitive transcriptional response for genes that are differentially expressed in Chd8−/−. (D) GO terms for DEGs. (E and F) Volcano plots of RNA-seq data for CHD8+/− and CHD8−/−. DEGs are highlighted in red (FDR < 0.05), and genes involved with mature neuronal development and Sox TFs are labeled. Genes labeled with yellow background were stained by IF in G. (G) Representative IF staining of day 8 NPCs, with antibodies listed on left side and respective genotypes on top (n = 2 biological replicates with similar results). Magnification: 200×.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: CHD8 dosage regulates transcription in pluripotency and early murine neural differentiation

doi: 10.1073/pnas.1921963117

Figure Lengend Snippet: CHD8 deletion results in up-regulation of neuronal genes and Sox TFs during differentiation into NPCs. (A) Schematic showing the differentiation of WT, Chd8+/−, and Chd8−/− ESCs into NPCs. (B) Venn diagrams depicting overlap of DEGs in Chd8+/− and Chd8−/− NPCs. Genes with increased gene expression are on top, and genes with decreased expression are on bottom (FDR < 0.05). (C) Heatmap showing dosage sensitive transcriptional response for genes that are differentially expressed in Chd8−/−. (D) GO terms for DEGs. (E and F) Volcano plots of RNA-seq data for CHD8+/− and CHD8−/−. DEGs are highlighted in red (FDR < 0.05), and genes involved with mature neuronal development and Sox TFs are labeled. Genes labeled with yellow background were stained by IF in G. (G) Representative IF staining of day 8 NPCs, with antibodies listed on left side and respective genotypes on top (n = 2 biological replicates with similar results). Magnification: 200×.

Article Snippet: Antibodies used in this study are mouse a-FLAG M2 (1:1,000, Sigma-Aldrich), rabbit a-CHD8 (1:2,500, Novus Biologicals #NB100-60417; 1:2,000, Novus Biologicals #NB100-60418), mouse a-TBP (1:2,000, Abcam #ab818), rabbit a-DCX (1:200, CST #4604S), mouse a-Nestin (1:200, #MAB353), mouse a-Tuj1 (1:200, BioLegend #801201), rabbit a-Pax6 (1:200, BioLegend #901301), rabbit a-NeuroD1 (1:200, Proteintech #12081-1-AP), and mouse a-Map2a (1:200, M9942).

Techniques: Gene Expression, Expressing, RNA Sequencing, Labeling, Staining

CHD8 regulates accessibility at key regions in ESCs and during differentiation to NPCs. (A) Percentage of increased (blue) and decreased (orange) peaks for Chd8−/− ESCs. (B) Genomic annotation enrichment for increased and decreased sites for Chd8−/− ESC ATAC-seq datasets. (C) Percentage of increased (blue) and decreased (orange) peaks for Chd8−/− NPCs. (D) Genomic annotation enrichment for increased and decreased sites for Chd8+/−and Chd8−/− NPC ATAC-seq datasets. (E) Genome tracks showing gain of accessibility at Grb10 locus in ESCs. (F) Genome tracks showing loss of accessibility at Basp1 locus in NPCs.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: CHD8 dosage regulates transcription in pluripotency and early murine neural differentiation

doi: 10.1073/pnas.1921963117

Figure Lengend Snippet: CHD8 regulates accessibility at key regions in ESCs and during differentiation to NPCs. (A) Percentage of increased (blue) and decreased (orange) peaks for Chd8−/− ESCs. (B) Genomic annotation enrichment for increased and decreased sites for Chd8−/− ESC ATAC-seq datasets. (C) Percentage of increased (blue) and decreased (orange) peaks for Chd8−/− NPCs. (D) Genomic annotation enrichment for increased and decreased sites for Chd8+/−and Chd8−/− NPC ATAC-seq datasets. (E) Genome tracks showing gain of accessibility at Grb10 locus in ESCs. (F) Genome tracks showing loss of accessibility at Basp1 locus in NPCs.

Article Snippet: Antibodies used in this study are mouse a-FLAG M2 (1:1,000, Sigma-Aldrich), rabbit a-CHD8 (1:2,500, Novus Biologicals #NB100-60417; 1:2,000, Novus Biologicals #NB100-60418), mouse a-TBP (1:2,000, Abcam #ab818), rabbit a-DCX (1:200, CST #4604S), mouse a-Nestin (1:200, #MAB353), mouse a-Tuj1 (1:200, BioLegend #801201), rabbit a-Pax6 (1:200, BioLegend #901301), rabbit a-NeuroD1 (1:200, Proteintech #12081-1-AP), and mouse a-Map2a (1:200, M9942).

Techniques:

CHD8 cooperates with Sox TFs to regulate accessibility and transcription. (A) Heatmap representation of ATAC-seq chromVAR bias-corrected deviations in the 50 most variable TF motifs across ESC WT and Chd8−/− ATAC-seq replicates. (B) Heatmap representation of ATAC-seq chromVAR bias-corrected deviations in the 50 most variable TF motifs across NPC WT and Chd8−/− ATAC-seq replicates. (C) Western blot showing co-IP of CHD8 with SOX2 in ESCs (antibodies used are the following: SOX2 A: sc-365823; SOX2 B: AB5603). (D) Heat map displaying CHD8 ChIP-seq at SOX2 peaks (41) (Left) and SOX2 ChIP-seq at CHD8 peaks (Right).

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: CHD8 dosage regulates transcription in pluripotency and early murine neural differentiation

doi: 10.1073/pnas.1921963117

Figure Lengend Snippet: CHD8 cooperates with Sox TFs to regulate accessibility and transcription. (A) Heatmap representation of ATAC-seq chromVAR bias-corrected deviations in the 50 most variable TF motifs across ESC WT and Chd8−/− ATAC-seq replicates. (B) Heatmap representation of ATAC-seq chromVAR bias-corrected deviations in the 50 most variable TF motifs across NPC WT and Chd8−/− ATAC-seq replicates. (C) Western blot showing co-IP of CHD8 with SOX2 in ESCs (antibodies used are the following: SOX2 A: sc-365823; SOX2 B: AB5603). (D) Heat map displaying CHD8 ChIP-seq at SOX2 peaks (41) (Left) and SOX2 ChIP-seq at CHD8 peaks (Right).

Article Snippet: Antibodies used in this study are mouse a-FLAG M2 (1:1,000, Sigma-Aldrich), rabbit a-CHD8 (1:2,500, Novus Biologicals #NB100-60417; 1:2,000, Novus Biologicals #NB100-60418), mouse a-TBP (1:2,000, Abcam #ab818), rabbit a-DCX (1:200, CST #4604S), mouse a-Nestin (1:200, #MAB353), mouse a-Tuj1 (1:200, BioLegend #801201), rabbit a-Pax6 (1:200, BioLegend #901301), rabbit a-NeuroD1 (1:200, Proteintech #12081-1-AP), and mouse a-Map2a (1:200, M9942).

Techniques: Western Blot, Co-Immunoprecipitation Assay, ChIP-sequencing

Basic demographics according to NRGN rs12541 and  rs12807809  genotype.

Journal: PLoS ONE

Article Title: The Impact of Genome-Wide Supported Schizophrenia Risk Variants in the Neurogranin Gene on Brain Structure and Function

doi: 10.1371/journal.pone.0076815

Figure Lengend Snippet: Basic demographics according to NRGN rs12541 and rs12807809 genotype.

Article Snippet: No allele frequency differences were observed for rs12807809 (Chi-Square test Hapmap χ 2 =1.333, p=0.248; Chi-Square test MCIC χ 2 =2.667, p=0.102).

Techniques:

a) Cortical statistical map illustrating reduced cortical thickness for rs12807809 C carriers compared to TT homozygotes. The -log(CWP-value) is represented according to the color code. b) Boxplot showing mean and two standard errors of the standardized residuals for the effects of NRGN rs12807809 genotype on left rostal ACC volume controlled for intracranial volume, age, gender, diagnosis and scanner field strength.

Journal: PLoS ONE

Article Title: The Impact of Genome-Wide Supported Schizophrenia Risk Variants in the Neurogranin Gene on Brain Structure and Function

doi: 10.1371/journal.pone.0076815

Figure Lengend Snippet: a) Cortical statistical map illustrating reduced cortical thickness for rs12807809 C carriers compared to TT homozygotes. The -log(CWP-value) is represented according to the color code. b) Boxplot showing mean and two standard errors of the standardized residuals for the effects of NRGN rs12807809 genotype on left rostal ACC volume controlled for intracranial volume, age, gender, diagnosis and scanner field strength.

Article Snippet: No allele frequency differences were observed for rs12807809 (Chi-Square test Hapmap χ 2 =1.333, p=0.248; Chi-Square test MCIC χ 2 =2.667, p=0.102).

Techniques: Biomarker Discovery

KEY RESOURCES TABLE

Journal: Cell stem cell

Article Title: Lipid Deprivation Induces a Stable, Naive-to-Primed Intermediate State of Pluripotency in Human PSCs

doi: 10.1016/j.stem.2019.05.001

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Rabbit anti-p44/42 MAPK (Phospho-ERK1/2) , Cell Signaling , 9101; RRID:AB_331646.

Techniques: Recombinant, Knock-Out, Reverse Transcription, Membrane, Methylation, Staining, Bisulfite Sequencing, RNA Sequencing, ChIP-sequencing, ChIP-qPCR, Control, Software, Magnetic Cell Separation, Protease Inhibitor

(A) Protein-protein interaction network analysis was used to clarify the molecular pathways that regulate two functionally distinct fibrosis subtypes: adaptive and pathogenic. Genes related to dermal and vascular fibrosis were collected from the curated literature, focusing on pulmonary arterial hypertension (PAH) as a human disease correlate to these findings in silico. Genes specifically associated with lung fibrosis (n = 362) were excluded from the analysis to limit the probability of analyzing pathways responsible for lung parenchymal fibrosis rather than pulmonary vascular fibrosis. (B) The gene products (proteins) associated with adaptive fibrosis (blue), pathogenic fibrosis (red), or both adaptive and pathogenic fibrosis (blue with red border) were mapped to the consolidated human protein-protein interactome (12), resulting in the fibrosome. (C) An aldosterone (ALDO)-fibrosome protein-protein interactome subnetwork resulting from associations involving fibrosis genes connected to ALDO-regulated genes. Arrow points to the SMAD3 target and Cas protein NEDD9. (D) Betweenness centrality (BC), a measure of importance in information transfer across the network of a node (protein) based on the shortest paths, was used to identify NEDD9 as a critical node in the phenotype transition from adaptive to pathogenic fibrosis. BC of an ALDO-regulated gene (ai) in connecting adaptive and pathogenic fibrosis (F1 and F2, respectively) is the sum of the fraction of all fibrosis gene pairs’ shortest paths in the interactome that pass through this ALDO-regulated gene (t) in the interactome, and σ(s,t|ai) is the number of those shortest paths in the interactome that pass through ALDO-regulated gene ai. The BC score for NEDD9 was ranked 6th of 86 proteins.

Journal: Science translational medicine

Article Title: NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension

doi: 10.1126/scitranslmed.aap7294

Figure Lengend Snippet: (A) Protein-protein interaction network analysis was used to clarify the molecular pathways that regulate two functionally distinct fibrosis subtypes: adaptive and pathogenic. Genes related to dermal and vascular fibrosis were collected from the curated literature, focusing on pulmonary arterial hypertension (PAH) as a human disease correlate to these findings in silico. Genes specifically associated with lung fibrosis (n = 362) were excluded from the analysis to limit the probability of analyzing pathways responsible for lung parenchymal fibrosis rather than pulmonary vascular fibrosis. (B) The gene products (proteins) associated with adaptive fibrosis (blue), pathogenic fibrosis (red), or both adaptive and pathogenic fibrosis (blue with red border) were mapped to the consolidated human protein-protein interactome (12), resulting in the fibrosome. (C) An aldosterone (ALDO)-fibrosome protein-protein interactome subnetwork resulting from associations involving fibrosis genes connected to ALDO-regulated genes. Arrow points to the SMAD3 target and Cas protein NEDD9. (D) Betweenness centrality (BC), a measure of importance in information transfer across the network of a node (protein) based on the shortest paths, was used to identify NEDD9 as a critical node in the phenotype transition from adaptive to pathogenic fibrosis. BC of an ALDO-regulated gene (ai) in connecting adaptive and pathogenic fibrosis (F1 and F2, respectively) is the sum of the fraction of all fibrosis gene pairs’ shortest paths in the interactome that pass through this ALDO-regulated gene (t) in the interactome, and σ(s,t|ai) is the number of those shortest paths in the interactome that pass through ALDO-regulated gene ai. The BC score for NEDD9 was ranked 6th of 86 proteins.

Article Snippet: The gene products (proteins) of the remaining fibrosis genes were mapped to the consolidated human protein-protein interactome (CHI) ( 12 ) to generate a network of fibrosis protein-protein interactions.

Techniques: In Silico

MEF2C binds to the upstream region of FOS gene and regulates NFATC1 expression. a A schematic view of FOS upstream regions with putative MEF2C binding sites predicted based on the analysis of MEF2C ChIP-sequencing data. b ChIP-qPCR analysis of the three putative MEF2C binding sites in the FOS upstream region. MEF2C binding was assessed in human OCPs transduced with adenoviral particles encoding GFP or MEF2C-FLAG and immunoprecipitated with FLAG antibodies. Dotted line represents enrichment level in the negative control HBB region in GFP transduced samples. ( n = 4) Mouse osteoclast precursor cells from MEF2C ΔMX KO or littermate control WT mice were transduced with retroviral particles encoding GFP or FOS and cultured with M-CSF and RANKL. c Representative image of TRAP staining of mouse osteoclasts. Scale bar, 100 μm. d Cumulative data showing numbers of osteoclasts from four independent experiments. Human osteoclast precursor cells were nucleofected with control or MEF2C #2 siRNAs. e RT-qPCR analysis of human NFATC1 mRNA after 48 h of culture with or without RANKL normalized relative to TBP mRNA (control samples with RANKL set at 1.0). n = 5. f Representative immunoblot of human NFATc1. p38 was used as a loading control. Right panel, densitometric quantitation of band intensity from three donors. Mouse osteoclast precursor cells from MEF2C ΔMX mice or littermate control WT mice were cultured with M-CSF and RANKL. g RT-qPCR analysis of mouse Nfatc1 mRNA after 24 h of culture with or without RANKL (50 ng·mL −1 ) normalized relative to Hprt mRNA (control samples without RANKL set at 1.0). WT; n = 11, KO; n = 12. h Representative images of immunoblotting analysis of mouse NFATc1 expression. Right panel, densitometric quantitation of band intensity from 4 samples of each genotype. Data are shown as mean ± SD. Statistics used: e repeated measurement two-way ANOVA, f paired t -test, g two-way ANOVA, h Welch’s t -test. * P < 0.05, ** P < 0.01, *** P < 0.001

Journal: Bone Research

Article Title: MEF2C regulates osteoclastogenesis and pathologic bone resorption via c-FOS

doi: 10.1038/s41413-020-00120-2

Figure Lengend Snippet: MEF2C binds to the upstream region of FOS gene and regulates NFATC1 expression. a A schematic view of FOS upstream regions with putative MEF2C binding sites predicted based on the analysis of MEF2C ChIP-sequencing data. b ChIP-qPCR analysis of the three putative MEF2C binding sites in the FOS upstream region. MEF2C binding was assessed in human OCPs transduced with adenoviral particles encoding GFP or MEF2C-FLAG and immunoprecipitated with FLAG antibodies. Dotted line represents enrichment level in the negative control HBB region in GFP transduced samples. ( n = 4) Mouse osteoclast precursor cells from MEF2C ΔMX KO or littermate control WT mice were transduced with retroviral particles encoding GFP or FOS and cultured with M-CSF and RANKL. c Representative image of TRAP staining of mouse osteoclasts. Scale bar, 100 μm. d Cumulative data showing numbers of osteoclasts from four independent experiments. Human osteoclast precursor cells were nucleofected with control or MEF2C #2 siRNAs. e RT-qPCR analysis of human NFATC1 mRNA after 48 h of culture with or without RANKL normalized relative to TBP mRNA (control samples with RANKL set at 1.0). n = 5. f Representative immunoblot of human NFATc1. p38 was used as a loading control. Right panel, densitometric quantitation of band intensity from three donors. Mouse osteoclast precursor cells from MEF2C ΔMX mice or littermate control WT mice were cultured with M-CSF and RANKL. g RT-qPCR analysis of mouse Nfatc1 mRNA after 24 h of culture with or without RANKL (50 ng·mL −1 ) normalized relative to Hprt mRNA (control samples without RANKL set at 1.0). WT; n = 11, KO; n = 12. h Representative images of immunoblotting analysis of mouse NFATc1 expression. Right panel, densitometric quantitation of band intensity from 4 samples of each genotype. Data are shown as mean ± SD. Statistics used: e repeated measurement two-way ANOVA, f paired t -test, g two-way ANOVA, h Welch’s t -test. * P < 0.05, ** P < 0.01, *** P < 0.001

Article Snippet: The antibodies used for immunoblotting are as follows: NFATc1 (#sc-7294), RANK (#sc-37436) (Santa Cruz Biotechnology, Dallas, TX, USA); MEF2C (#5030), c-Fos (#2250), IkBα (#9242), p-p38 (#9215), p-ERK1/2 (#9101), ERK1/2 (#9102), p65 (#4764), p105/p50 (#3035), and p38 (#9212) (Cell Signaling Technology, Danvers, MA, USA); Lamin B1 (Abcam #16048, Cambridge, UK); α-tubulin (Sigma-Aldrich #T9026, St. Louis, MO, USA); FLAG (for immunoblotting: Biolegend #637301, San Diego, CA, USA.

Techniques: Expressing, Binding Assay, ChIP-sequencing, ChIP-qPCR, Transduction, Immunoprecipitation, Negative Control, Control, Retroviral, Cell Culture, Staining, Quantitative RT-PCR, Western Blot, Quantitation Assay

JMJD2B expression increases in hepatic steatotic cell and animal models. ( A ) HepG2 cells were incubated with a mixture of palmitic acid (PA) and oleic acid (OA) (1:2 ratio) at 800 μM concentrations for 24 h, and intracellular triglyceride (TG) levels were analyzed by a TG assay kit. JMJD2B mRNA and protein levels were examined by qPCR and western blotting, respectively. Data represent means ± SEM of three independent experiments performed in triplicate. *p < 0.05 vs. no treatment. The full-length western blots corresponding to truncated blots are presented in Supplementary Figure . ( B ) HepG2 cells were treated with T0901317 (10 μM) for 24 h, and intracellular triglyceride (TG) levels were measured by a TG assay kit. JMJD2B mRNA and protein levels were examined by qPCR and western blotting, respectively. Data represent means ± SEM of three independent experiments performed in triplicate. *p < 0.05 vs. no treatment. The full-length western blots are presented in Supplementary Figure . ( C ) Total RNAs were isolated from the livers of HFD-induced obese mice. The JMJD2B mRNA levels were assessed by qPCR. Data represent means ± SEM of 5 mice. * p < 0.05 vs. ND mice. ND: normal diet. HFD: high fat diet.

Journal: Scientific Reports

Article Title: Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2

doi: 10.1038/s41598-018-31953-x

Figure Lengend Snippet: JMJD2B expression increases in hepatic steatotic cell and animal models. ( A ) HepG2 cells were incubated with a mixture of palmitic acid (PA) and oleic acid (OA) (1:2 ratio) at 800 μM concentrations for 24 h, and intracellular triglyceride (TG) levels were analyzed by a TG assay kit. JMJD2B mRNA and protein levels were examined by qPCR and western blotting, respectively. Data represent means ± SEM of three independent experiments performed in triplicate. *p < 0.05 vs. no treatment. The full-length western blots corresponding to truncated blots are presented in Supplementary Figure . ( B ) HepG2 cells were treated with T0901317 (10 μM) for 24 h, and intracellular triglyceride (TG) levels were measured by a TG assay kit. JMJD2B mRNA and protein levels were examined by qPCR and western blotting, respectively. Data represent means ± SEM of three independent experiments performed in triplicate. *p < 0.05 vs. no treatment. The full-length western blots are presented in Supplementary Figure . ( C ) Total RNAs were isolated from the livers of HFD-induced obese mice. The JMJD2B mRNA levels were assessed by qPCR. Data represent means ± SEM of 5 mice. * p < 0.05 vs. ND mice. ND: normal diet. HFD: high fat diet.

Article Snippet: The antibody against JMJD2B (NB100-74605) was purchased from Novus Biologicals (Littelton, CO, USA).

Techniques: Expressing, Incubation, Western Blot, Isolation

Overexpression of JMJD2B increases intracellular TG levels and stimulates PPARγ2 expression in HepG2 cells. HepG2 cells in 6-well plates were infected with Ad-GFP or Ad-JMJD2B. ( A ) The levels of JMJD2B, H3K9me, H3K9me2, and H3K9me3 were measured by western blotting. The full-length western blots corresponding to truncated blots are provided in Supplementary Figure . ( B ) Intracellular TG levels were measured by TG assay kit. ( C ) PPARγ2 expression was assessed by qPCR and western blotting. The full-length western blots corresponding to truncated blots are presented in Supplementary Figure . ( D , E ) The expression of PPARγ2 steatosis target genes was evaluated by qPCR. Data represent means ± SEM of three independent experiments performed in triplicate. * p < 0.05, ** p < 0.01 vs. Ad-GFP.

Journal: Scientific Reports

Article Title: Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2

doi: 10.1038/s41598-018-31953-x

Figure Lengend Snippet: Overexpression of JMJD2B increases intracellular TG levels and stimulates PPARγ2 expression in HepG2 cells. HepG2 cells in 6-well plates were infected with Ad-GFP or Ad-JMJD2B. ( A ) The levels of JMJD2B, H3K9me, H3K9me2, and H3K9me3 were measured by western blotting. The full-length western blots corresponding to truncated blots are provided in Supplementary Figure . ( B ) Intracellular TG levels were measured by TG assay kit. ( C ) PPARγ2 expression was assessed by qPCR and western blotting. The full-length western blots corresponding to truncated blots are presented in Supplementary Figure . ( D , E ) The expression of PPARγ2 steatosis target genes was evaluated by qPCR. Data represent means ± SEM of three independent experiments performed in triplicate. * p < 0.05, ** p < 0.01 vs. Ad-GFP.

Article Snippet: The antibody against JMJD2B (NB100-74605) was purchased from Novus Biologicals (Littelton, CO, USA).

Techniques: Over Expression, Expressing, Infection, Western Blot

Knockdown of JMJD2B reduces the intracellular TG level and represses PPARγ2 expression in HepG2 cells. HepG2 cells in 6-well plates were transfected with scramble RNA or JMJD2B siRNA. ( A ) The levels of JMJD2B, H3K9me, H3K9me2, and H3K9me3 were measured by western blotting. The full-length western blots corresponding to truncated blots are presented in Supplementary Figure . ( B ) Intracellular TG levels were measured by a TG assay kit. ( C ) PPARγ2 expression was assessed by qPCR and western blotting. The full-length western blots corresponding to truncated blots are presented in Supplementary Figure . ( D , E ) The expression of PPARγ2 steatosis target genes was evaluated by qPCR. Data represent means ± SEM of three independent experiments performed in triplicate. * p < 0.05 vs. scramble RNA.

Journal: Scientific Reports

Article Title: Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2

doi: 10.1038/s41598-018-31953-x

Figure Lengend Snippet: Knockdown of JMJD2B reduces the intracellular TG level and represses PPARγ2 expression in HepG2 cells. HepG2 cells in 6-well plates were transfected with scramble RNA or JMJD2B siRNA. ( A ) The levels of JMJD2B, H3K9me, H3K9me2, and H3K9me3 were measured by western blotting. The full-length western blots corresponding to truncated blots are presented in Supplementary Figure . ( B ) Intracellular TG levels were measured by a TG assay kit. ( C ) PPARγ2 expression was assessed by qPCR and western blotting. The full-length western blots corresponding to truncated blots are presented in Supplementary Figure . ( D , E ) The expression of PPARγ2 steatosis target genes was evaluated by qPCR. Data represent means ± SEM of three independent experiments performed in triplicate. * p < 0.05 vs. scramble RNA.

Article Snippet: The antibody against JMJD2B (NB100-74605) was purchased from Novus Biologicals (Littelton, CO, USA).

Techniques: Knockdown, Expressing, Transfection, Western Blot

JMJD2B lessens the enrichment of H3K9me2 and H3K9me3 on PPARγ2 promoters and increases the binding of PPARγ2 to PPREs on promoters of CD36 and PLIN2 . HepG2 cells were infected with adenovirus Ad-GFP or Ad-JMJD2B. ( A ) The recruitment of JMJD2B to the PPARγ2 promoter was analyzed by ChIP-qPCR. ( B ) The enrichment of H3K9me2 and H3K9me3 on promoters of PPARγ2 was analyzed by ChIP-qPCR. ( C ) The recruitment of PPARγ2 to PPRE on promoters of CD36 and PLIN2 was assessed by ChIP-qPCR. Data represent means ± SEM of three independent experiments performed in triplicate. * p < 0.05, ** p < 0.01 vs. Ad-GFP.

Journal: Scientific Reports

Article Title: Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2

doi: 10.1038/s41598-018-31953-x

Figure Lengend Snippet: JMJD2B lessens the enrichment of H3K9me2 and H3K9me3 on PPARγ2 promoters and increases the binding of PPARγ2 to PPREs on promoters of CD36 and PLIN2 . HepG2 cells were infected with adenovirus Ad-GFP or Ad-JMJD2B. ( A ) The recruitment of JMJD2B to the PPARγ2 promoter was analyzed by ChIP-qPCR. ( B ) The enrichment of H3K9me2 and H3K9me3 on promoters of PPARγ2 was analyzed by ChIP-qPCR. ( C ) The recruitment of PPARγ2 to PPRE on promoters of CD36 and PLIN2 was assessed by ChIP-qPCR. Data represent means ± SEM of three independent experiments performed in triplicate. * p < 0.05, ** p < 0.01 vs. Ad-GFP.

Article Snippet: The antibody against JMJD2B (NB100-74605) was purchased from Novus Biologicals (Littelton, CO, USA).

Techniques: Binding Assay, Infection, ChIP-qPCR

Adenovirus-mediated JMJD2B overexpression stimulated hepatic steatosis in vivo . C57BL/6 mice (8 weeks old) were injected with adenovirus Ad-GFP or Ad-JMJD2B. After injection, Ad-injected mice were fed a HFD for 2 weeks. ( A ) JMJD2B expression was determined by qPCR ( B ) Immunostaining of JMJD2B (scale bar = 50 μm). Representative photographs are shown. JMJD2B positive cells were counted in ten random areas at 400× magnification and analyzed by using image J. Quantification of immunostaining assay is represented as percentage of JMJD2B positive cells. ( C ) Hepatic triglyceride (TG) levels were measured by a TG assay kit. ( D ) Liver morphology, ORO and H&E staining (scale bar = 100 μm). Representative images are presented. ( E ) Serum total TG levels. ( F ) Serum total cholesterol levels. Data represent means ± SEM from 5 mice. * p < 0.05 vs. Ad-GFP-infected mice.

Journal: Scientific Reports

Article Title: Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2

doi: 10.1038/s41598-018-31953-x

Figure Lengend Snippet: Adenovirus-mediated JMJD2B overexpression stimulated hepatic steatosis in vivo . C57BL/6 mice (8 weeks old) were injected with adenovirus Ad-GFP or Ad-JMJD2B. After injection, Ad-injected mice were fed a HFD for 2 weeks. ( A ) JMJD2B expression was determined by qPCR ( B ) Immunostaining of JMJD2B (scale bar = 50 μm). Representative photographs are shown. JMJD2B positive cells were counted in ten random areas at 400× magnification and analyzed by using image J. Quantification of immunostaining assay is represented as percentage of JMJD2B positive cells. ( C ) Hepatic triglyceride (TG) levels were measured by a TG assay kit. ( D ) Liver morphology, ORO and H&E staining (scale bar = 100 μm). Representative images are presented. ( E ) Serum total TG levels. ( F ) Serum total cholesterol levels. Data represent means ± SEM from 5 mice. * p < 0.05 vs. Ad-GFP-infected mice.

Article Snippet: The antibody against JMJD2B (NB100-74605) was purchased from Novus Biologicals (Littelton, CO, USA).

Techniques: Over Expression, In Vivo, Injection, Expressing, Immunostaining, Staining, Infection

Adenovirus-mediated JMJD2B overexpression promotes the expression of PPARγ2 and its steatosis target genes in mouse liver. C57BL/6 mice (8 weeks old) were injected with adenovirus Ad-GFP or Ad-JMJD2B. After injection, Ad-injected mice were fed a HFD for 2 weeks. ( A ) PPARγ2 expression was measured by qPCR. ( B , C ) The expression of PPARγ2 steatosis target genes was measured by qPCR. Data represent means ± SEM from 5 mice. * p < 0.05, ** p < 0.01 vs. Ad-GFP-infected mice.

Journal: Scientific Reports

Article Title: Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2

doi: 10.1038/s41598-018-31953-x

Figure Lengend Snippet: Adenovirus-mediated JMJD2B overexpression promotes the expression of PPARγ2 and its steatosis target genes in mouse liver. C57BL/6 mice (8 weeks old) were injected with adenovirus Ad-GFP or Ad-JMJD2B. After injection, Ad-injected mice were fed a HFD for 2 weeks. ( A ) PPARγ2 expression was measured by qPCR. ( B , C ) The expression of PPARγ2 steatosis target genes was measured by qPCR. Data represent means ± SEM from 5 mice. * p < 0.05, ** p < 0.01 vs. Ad-GFP-infected mice.

Article Snippet: The antibody against JMJD2B (NB100-74605) was purchased from Novus Biologicals (Littelton, CO, USA).

Techniques: Over Expression, Expressing, Injection, Infection

Gomisin N (GN) represses the expression of JMJD2B, PPARγ2, and PPARγ2 steatosis target genes in HepG2 cells. HepG2 cells were treated with GN (100 μM) for 12 h. ( A ) JMJD2B expression was assessed by qPCR and western blotting. The full-length western blots corresponding to truncated blots are given in Supplementary Figure . ( B ) PPARγ2 expression was measured by qPCR. ( C , D ) The expression of PPARγ2 steatosis target genes was assessed by qPCR. Data represent means ± SEM of three independent experiments performed in triplicate. * p < 0.05 vs. no treatment.

Journal: Scientific Reports

Article Title: Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2

doi: 10.1038/s41598-018-31953-x

Figure Lengend Snippet: Gomisin N (GN) represses the expression of JMJD2B, PPARγ2, and PPARγ2 steatosis target genes in HepG2 cells. HepG2 cells were treated with GN (100 μM) for 12 h. ( A ) JMJD2B expression was assessed by qPCR and western blotting. The full-length western blots corresponding to truncated blots are given in Supplementary Figure . ( B ) PPARγ2 expression was measured by qPCR. ( C , D ) The expression of PPARγ2 steatosis target genes was assessed by qPCR. Data represent means ± SEM of three independent experiments performed in triplicate. * p < 0.05 vs. no treatment.

Article Snippet: The antibody against JMJD2B (NB100-74605) was purchased from Novus Biologicals (Littelton, CO, USA).

Techniques: Expressing, Western Blot